A breakthrough tech to recreate in vitro organs
Our BIOMIMESYS® 3D cell culture technology reproduces the natural microenvironment of any human organ or tissue of interest
Ensures more predictive results from artificially created cellular environment studies.
Reduces the time and costs of the drug discovery research and development process
Provides lab-reconstructed skin replacing cosmetic tests on animals
Recreates efficiently grow-lab meat for human consumption

Our technology
About us
HCS Pharma is a biotechnology company that develops and distributes products to grow and process either human or animal cells in an artificially created organ-like environment. Its technology is based on a 3D cell culture system that better replicates the biological environment allowing better results for research and testing. HCS Pharma's leading product is BIOMIMESYS® HydroscaffoldTM which is offered to their customers from diverse industries such as pharmaceutical, dermo-cosmetic, and agri-food industries.
Our technology
BIOMIMESYS® is a ground-breaking 3D technology that enables the faithful reproduction of the microenvironment (called Extra-Cellular Matrix) of any organ, healthy or cancerous. It is also the only ready-to-use organ-specific 3D technology based on natural components and usable in high throughput settings.

Current 2D technologies return a 90% failure rate on new drugs testing, BioMIMESYS 3D technology will make it a 90% successful rate.
Our solutions
Regenerative Medicine
Cell Therapy
Drug Discovery
Cultivated Meat
* synthetic methods which mimic biochemical processes (Source)
$8.5 Billion
by 2026*
Biomimetic market focused on Regenerative Medicine is estimated to reach
BIOMIMESYS® technology allows you to spend less time and fewer resources on lab-grown human organs reproduction.
Slow development in lab-grown human organs industry due to the current inefficient technology
* synthetic methods which mimic biochemical processes (Source)
$8.5 Billion
by 2026*
Biomimetic market focused on Cell Therapy is estimated to reach
BIOMIMESYS® technology recreates the right stable environment to keep cells alive, to let them grow, and to differentiate them
Lack of technologies able to recreate functional life being systems, not allowing cells to grow
$15 Billion
by 2026
3D Cell Culture Market in Drug Discovery is estimated to reach
BIOMIMESYS® allows the study of drug molecules in environments more similar to the human body reducing trials failure
Lack of functional lab-grow cellular environments which leads to continuous failure on drug trials
$4.1 Billion
Artificial skin market is estimated to reach
BIOMIMESYS® is the only technology able to recreate all layers of the skin from young or old people
Banning testing on animals and poor development on lab-reconstructed skin affects cosmetic production
$518 Million
by 2026
Biomimetic market focused on Clean Meat is estimated to reach
BIOMIMESYS® low-cost and effective solution is capable to boost the industry keeping high standards on production feasibility and taste
High prices, low supply, and non-functional technology halt this industry development and its need to tackle climate change
Our achievements
Letters of Interest
Scientific papers
Key Start-Ups Company - Partnering and Medical Innovation Award 2021
France’s Research and Development tax credits allows the awarded companies, usually focused in deeptech area, to boost their Research and Development process.
The status of Young Innovative Company (JEI) recognize young companies very active in R&D. this distinction is given by the french ministry of research.
Key Start-Ups Company - Partnering and Medical Innovation Award 2021
France’s Research and Development tax credits allows the awarded companies, usually focused in deeptech area, to boost their Research and Development process.
The status of Young Innovative Company (JEI) recognize young companies very active in R&D. this distinction is given by the french ministry of research.
R&D projects (7)
Research (10)
Commercial (6)
Financial (4)
As we develop our own biological models, R&D is the heart of our company. We strongly believe in cooperation and we are part of several programmes:
Our Team
Executive Team
Business team
Scientific Board
Nathalie Maubon
Founder, Chief Executive Officer, Chief Scientific Officer
22 years in R&D in pharmaceutical research
Elodie Vandenhaute
In Vitro Pharmacology Project Manager
13 years of experience in R&D in cellular biology
Zied Souguir
Senior Scientist, Biomaterial Department Manager
20 years of experience in R&D in biometrical chemistry
Gregory Maubon
Chief Development Officer and IA Project Leader
22 years of experience
in IT/Digital field
Joseph Chou
30+ years of experience in entrepreneurship and BD in Tokyo Future Style
Mathieu Laouenan
33 years of experience in BD, General Manager of Waters in Asia
Fabienne Berthet
PhD, more than 15 years of experience in IP and BD in Healthcare
Patrick Squiban
34 years of experience as Medical Director in pharma & biotech
Luc Merquen
PhD, 28 years of experience in In Vitro Preclinical Research in Sanofi
Emmanuel Montet
MBA, 27 years of experience in global industrial operations Asia Pacific
PhD, IPS Expert
PhD, BBB Expert
PhD, Biochips Expert
MD, PhD, Neurologist
PhD, Oncology Expert
MD, PhD, Oncologist
MD, PhD, Neurology & Oncology
PhD, Hepatic infection and liver disease expert
Our Vision for 2031
Developing and deploying diverse specific BIOMIMESYS® models categorized by:
Renal Fibrosis
Liver Fibrosis
Adipose tissue
Our technology
Leading technology in the field of 3D Cell Culture, with applications in almost all fields of Life Sciences, Food production, and Dermo-cosmetology industries.
Global supplier in 3D Cell Culture technologies
Major supplier of lab-grow human cell/tissues/organs
Leader in Cultivated Meat industry
Strong player in Drug Discovery industry
Investor relations
Currently HCS Pharma is undergoing a capital raise campaign. Contact us on the email below for extra information:
Feel free to request information regarding any of the subject below:
Contact us
 Fill the form below
And get investment materials
© 2021 HCS Pharma | All Rights Reserved.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Read More

Privacy Policy - HCS Pharma

This policy sets out the different areas where user privacy is concerned and outlines the obligations & requirements of the users, the website and website owners. Furthermore, the way this website processes, stores and protects user data and information will also be detailed within this policy.

This website and its owners take a proactive approach to user privacy and ensure the necessary steps are taken to protect the privacy of its users throughout their visiting experience. This website complies with the EU General Data Protection Regulation (GDPR). Please read the information provided at knowyourprivacyrights.org to better know your rights and our obligations.

We regret that if there are one or more points below with which you are not happy, your only recourse is to leave our website immediately.

Who we are ?

This is the privacy notice of HCS pharma, refered in this document as “we”, “our”, or “us”. This privacy policy is available for all activities of HCS Pharma and for websites https://hcs-pharma.com and https://biomimesys.com/

Our data treatment is registered at French CNIL under number 1750482

SAS HCS Pharma – Siège de Lille, Biocentre Fleming, 250 rue Salvador Allende, Bat A, 59120 Loos

For any question about your data, please contact us with this form.

Use of cookies

What are cookies?

Cookies are small files saved to the user’s computer’s hard drive that track, save and store information about the user’s interactions and usage of the website. This allows the website, through its server to provide the users with a tailored experience within this website.

What do we use cookies for?

We may use cookies to remember personal settings you have chosen at our website. In no other context do we use cookies to collect information that identifies you personally. Most of the cookies we set are automatically deleted from your computer when you leave our website or shortly afterwards.

We use anonymous session cookies (short-term cookies that disappear when you close your browser) to help you navigate the website and make the most of the features. If you log into the website, application or a course as a registered user, your session cookie will also contain your user ID so that we can check which services you are allowed to access.

This website uses tracking software to monitor its visitors to better understand how they use it. This software is provided by Google Analytics which uses cookies to track visitor usage. The software will save a cookie to your computer’s hard drive in order to track and monitor your engagement and usage of the website, but will not store, save or collect personal information.

Information collection and use

How do we collect information?

HCS Pharma collects information in two possible ways:

  1. When you sign up for our site, purchase our products or communicate with us, you may choose to voluntarily give us certain information – for example, by filling in text boxes or completing registration forms. All this information requires a direct action by you at that time in order for us to receive it.
  2. Depending on your settings or the privacy policies for other online services, you may give us permission to obtain information from your account with those other services. For example, this can be via social media or by choosing to send us your location data when accessing our website from your smartphone

How long do we keep your data for?

HCS Pharma will not retain your personal information longer than necessary. We will hold onto the information you provide either while your account is in existence, or as needed to be able to provide the Services to you, or (in the case of any contact you may have with our Customer Care team) for as long as is necessary to provide support-related reporting and trend analysis only.

If legally required or if it is reasonably necessary to meet regulatory requirements, resolve disputes, prevent fraud and abuse, or enforce our Terms and Conditions, we may also retain some of your information for a limited period of time as required, even after you have closed your account or it is no longer needed to provide the Services to you.

Registration forms

HCS Pharma will not sell or rent your personally identifiable information, gathered as a result of filling out the site registration form, to anyone. We understand that you trust us with your personal information and we are committed to ensuring you can manage the privacy and security of your personal information yourself.

With respect to the information relating to you that ends up in our possession, and recognising that it is your choice to provide us with your personally identifiable information, we commit to giving you the ability to do all of the following:

  • You can verify the details you have submitted to HCS pharma by contacting us. Our security procedures mean that we may request proof of identity before we reveal information, including your e-mail address and possibly your address.
  • You can also contact us by the same method to change, correct, or delete your personal information controlled by HCS Pharma regarding your profile at any time. Please note though that, if you have shared any information with others through social media channels, that information may remain visible, even if your account is delete.
  • You can unsubscribe from receiving marketing emails from us by clicking the “unsubscribe” link at the bottom of any email. Once you do this, you will no longer receive any emails from us.

Please note, we are constantly reviewing how we process and protect data. Therefore, changes to our policy may occur at any time. We will endeavor to publicize any changes.